GlassScriptPhysician profile
Bikramjit Singh
NPI 1033156591
$808.25
in general payments reported to CMS, 2019-2025
19 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $171 · 2021: $97.42 · 2022: $127 · 2023: $88.94 · 2024: $36.76 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $129.58 | 2024-2025 | Freestyle Libre 3 |
| Amgen INC. | $88.60 | 2021-2022 | |
| Boston Scientific Corporation | $82.55 | 2020 | |
| Baxter Healthcare | $74.93 | 2023 | Renal - Pd |
| Horizon Therapeutics Plc | $65.71 | 2019-2020 | |
| Glaxosmithkline, LLC. | $54.39 | 2019-2021 | |
| Novo Nordisk INC | $53.68 | 2019-2022 | |
| Amarin Pharma, INC. | $52.09 | 2019-2020 | |
| Aurinia Pharma U.S., INC. | $47.76 | 2021-2022 | |
| Exact Sciences Corporation | $32.24 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $20.45 | 2021 | |
| Calliditas Therapeutics US INC. | $14.70 | 2025 | Tarpeyo |
| Lilly USA, LLC | $14.55 | 2019 | |
| Pfizer INC. | $14.01 | 2023 | |
| Siemens Medical Solutions USA, INC. | $13.93 | 2024 | Acuson Sc2000 Diagnostic Ultrasound System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $13.63 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.02 | 2022 | |
| Merck Sharp & Dohme LLC | $11.47 | 2020 | |
| Sanofi-Aventis U.S. LLC | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bikramjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.